About AVEO Pharmaceuticals
AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough and Biogen Idec.
|
|
|
11-50 employees
View all AVEO Pharmaceuticals employees
|
|
Health Care
|
|
Cambridge, MA
|
|
2001
|
AVEO Pharmaceuticals Alternatives
Frequently Asked Questions about AVEO Pharmaceuticals
The decision makers in AVEO Pharmaceuticals are Arvind Sharma, Dennis Vargo, Jean Kaufman, etc. Click to Find AVEO Pharmaceuticals decision makers emails.
AVEO Pharmaceuticals Staff Directory
Search AVEO Pharmaceuticals Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
